Not Accessible: Data From Pivotal Trials of New Cancer Drugs

Individual patient data is available for less than half of the clinical trials that underpin the FDA approval of new cancer drugs, a new analysis reveals.
Medscape Medical News

source https://www.medscape.com/viewarticle/978603?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?